GENE - Genetic Technologies Limited

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
-0.0259 (-2.60%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close0.9949
Bid0.000 x 3000
Ask1.210 x 800
Day's Range0.9500 - 1.0100
52 Week Range0.8900 - 2.0500
Avg. Volume69,158
Market Cap15.857M
Beta (3Y Monthly)3.95
PE Ratio (TTM)N/A
EPS (TTM)-0.300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.50
Trade prices are not sourced from all markets
  • GlobeNewswire3 months ago

    Genetic Technologies Invited to Establish a Market Presence in Hainan, China

    MELBOURNE, Australia, Sept. 17, 2018-- Hainan Resort Software Community has on behalf of Hainan Ecological Smart City Group formally extended an invitation to Genetic Technologies Limited to establish ...

  • ACCESSWIRE5 months ago

    Today’s Research Reports on Stocks to Watch: Genetic Technologies and Innovate Biopharmaceuticals

    NEW YORK, NY / ACCESSWIRE / July 17, 2018 / Genetic Technologies saw big gains on news that its breast cancer and colorectal cancer risk assessment tests are on track. Shares of Innovate were headed in the opposite direction on news that the company has filed a securities registration statement amendment with the SEC to issue up to $175 million of new stock and to sell 14 million shares of existing stock. Innovate Biopharmaceuticals, Inc.

  • Genetic Technologies Stock Up on Genetic Test Update
    Market Realist5 months ago

    Genetic Technologies Stock Up on Genetic Test Update

    Today, Genetic Technologies (GENE) was trading over 70% higher than yesterday’s closing price of $1.09. The stock jumped ~72.5% in premarket trading. The stock price and volumes rose on the news of the company’s on-track breast cancer and colorectal cancer risk assessment tests, slated for release in October.

  • Benzinga5 months ago

    Benzinga Pro's 5 Stocks To Watch Today

    Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Coda Octopus Group, Inc. (NASDAQ: CODA ) stock soared ...

  • Investopedia6 months ago

    Why KISS Rocker Gene Simmons Sees Dow 30,000

    Beyond 30,000, that’s where the Dow Jones Industrial Average (DJIA) is headed, according to Gene Simmons, known by many rock n’ roll fans as the KISS Demon. As of the close of trading on Tuesday, the Dow was sitting around 24,360, down 1.5% on the year. Since 1985, the Dow has gone through good times and bad, but has risen overall by nearly 1,800%.

  • Invictus MD Strategies Corp. Opens the Market
    CNW Group9 months ago

    Invictus MD Strategies Corp. Opens the Market

    Invictus MD Strategies Corp. Opens the Market

  • PR Newswire9 months ago

    Invictus MD Strategies Corp. Opens the Market

    TORONTO , March 20, 2018 /CNW/ - Dan Kriznic , Chairman, CEO, Founder & Director, alongside Gene Simmons , Co-Founder of KISS, and Chief Evangelist Officer, Invictus MD Strategies Corp. (GENE), joined ...

  • PR Newswire9 months ago

    Shivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data Analysis

    NASDAQ: GENE) to accelerate the prediction of cancer for millions of individuals worldwide. GTG, whose lead product is BREVAGenplus® - a clinically validated risk assessment test for non-hereditary breast cancer - is at the forefront of preventive medicine.